Commit To Buy Coherus BioSciences At $17.50, Earn 35.8% Annualized Using Options
May 06, 2016 at 11:36 AM EDT
Investors eyeing a purchase of Coherus BioSciences Inc (CHRS) stock, but tentative about paying the going market price of $18.75/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $17.50 strike, which has a bid at the time of this writing of $1.80..